Natural history, dynamics, and ecology of human papillomaviruses in genital infections of young women: protocol of the PAPCLEAR cohort study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
11 06 2019
Historique:
entrez: 14 6 2019
pubmed: 14 6 2019
medline: 19 5 2020
Statut: epublish

Résumé

Human papillomaviruses (HPVs) are responsible for one-third of all cancers caused by infections. Most HPV studies focus on chronic infections and cancers, and we know little about the early stages of the infection. Our main objective is to better understand the course and natural history of cervical HPV infections in healthy, unvaccinated and vaccinated, young women, by characterising the dynamics of various infection-related populations (virus, epithelial cells, vaginal microbiota and immune effectors). Another objective is to analyse HPV diversity within hosts, and in the study population, in relation to co-factors (lifestyle characteristics, vaccination status, vaginal microbiota, human genetics). The PAPCLEAR study is a single center longitudinal study following 150 women, aged 18-25 years, for up to 2 years. Visits occur every 2 or 4 months (depending on HPV status) during which several variables are measured, such as behaviours (via questionnaires), vaginal pH, HPV presence and viral load (via qPCR), local concentrations of cytokines (via MesoScale Discovery technology) and immune cells (via flow cytometry). Additional analyses are outsourced, such as titration of circulating anti-HPV antibodies, vaginal microbiota sequencing (16S and ITS1 loci) and human genotyping. To increase the statistical power of the epidemiological arm of the study, an additional 150 women are screened cross-sectionally. Finally, to maximise the resolution of the time series, participants are asked to perform weekly self-samples at home. Statistical analyses will involve classical tools in epidemiology, genomics and virus kinetics, and will be performed or coordinated by the Centre National de la Recherche Scientifique (CNRS) in Montpellier. This study has been approved by the Comité de Protection des Personnes Sud Méditerranée I (reference number 2016-A00712-49); by the Comité Consultatif sur le Traitement de l'Information en matière de Recherche dans le domaine de la Santé (reference number 16.504); by the Commission Nationale Informatique et Libertés (reference number MMS/ABD/AR1612278, decision number DR-2016-488) and by the Agence Nationale de Sécurité du Médicament et des Produits de Santé (reference 20160072000007). Results will be published in preprint servers, peer-reviewed journals and disseminated through conferences. NCT02946346; Pre-results.

Identifiants

pubmed: 31189673
pii: bmjopen-2018-025129
doi: 10.1136/bmjopen-2018-025129
pmc: PMC6576111
doi:

Substances chimiques

Cytokines 0

Banques de données

ClinicalTrials.gov
['NCT02946346']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e025129

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Infect Dis. 2014 Dec 1;210(11):1723-33
pubmed: 24943724
Mucosal Immunol. 2017 Sep;10(5):1310-1319
pubmed: 28120845
Lancet Infect Dis. 2009 Jun;9(6):347-56
pubmed: 19467474
N Engl J Med. 2006 Jun 22;354(25):2645-54
pubmed: 16790697
N Engl J Med. 2015 Feb 19;372(8):711-23
pubmed: 25693011
Biochemistry (Mosc). 2008 May;73(5):498-503
pubmed: 18605974
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4680-7
pubmed: 20534435
Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):709-15
pubmed: 17416761
Cancer Discov. 2011 Oct;1(5):408-19
pubmed: 22586631
Prev Med. 2011 Oct;53 Suppl 1:S12-21
pubmed: 21962466
J Natl Cancer Inst. 2008 Apr 2;100(7):513-7
pubmed: 18364507
J Reprod Immunol. 2016 Feb;113:42-9
pubmed: 26637953
Eur J Dermatol. 2014 Sep-Oct;24(5):611-6
pubmed: 25322708
Trends Genet. 2015 Jan;31(1):41-54
pubmed: 25467628
J Infect Dis. 2009 Apr 1;199(7):919-22
pubmed: 19236278
Sci Transl Med. 2012 May 2;4(132):132ra52
pubmed: 22553250
J Vis Exp. 2014 Jul 06;(89):
pubmed: 25045942
Presse Med. 2014 Dec;43(12 Pt 2):e413-21
pubmed: 25448124
PLoS Comput Biol. 2019 Jan 23;15(1):e1006646
pubmed: 30673699
J Infect Dis. 2008 May 15;197(10):1436-47
pubmed: 18419547
Vaccine. 2018 Aug 28;36(36):5416-5423
pubmed: 28801154
Viruses. 2017 Oct 10;9(10):
pubmed: 28994707
Mucosal Immunol. 2012 May;5(3):277-87
pubmed: 22318497
J Theor Biol. 2000 Apr 7;203(3):285-301
pubmed: 10716909
Nat Genet. 2013 Aug;45(8):918-22
pubmed: 23817570
Vaccine. 2011 Apr 27;29(19):3610-6
pubmed: 21382486
BMC Infect Dis. 2013 Jun 10;13:271
pubmed: 23758857
Nature. 2013 Jun 20;498(7454):367-70
pubmed: 23698366
Trends Microbiol. 2009 May;17(5):205-11
pubmed: 19375325
J Med Virol. 2014 Mar;86(3):536-45
pubmed: 24114972
BMC Public Health. 2015 May 02;15:453
pubmed: 25934423
Hum Mol Genet. 2015 May 1;24(9):2681-8
pubmed: 25616963
PLoS Biol. 2018 Jan 18;16(1):e2003815
pubmed: 29346373
N Engl J Med. 2002 Nov 21;347(21):1645-51
pubmed: 12444178
J Pharmacokinet Pharmacodyn. 2014 Oct;41(5):431-43
pubmed: 24961742
Science. 2007 Aug 17;317(5840):944-7
pubmed: 17641165
Lancet Oncol. 2015 May;16(5):e206-16
pubmed: 25943065
J Infect Dis. 2016 Sep 1;214(5):665-75
pubmed: 27009602
Gynecol Obstet Fertil. 2013 May;41(5):305-13
pubmed: 23647817
Nat Rev Cancer. 2007 Jan;7(1):11-22
pubmed: 17186016
J Clin Microbiol. 2000 Jan;38(1):357-61
pubmed: 10618116
Clin Chem Lab Med. 2011 Dec 20;50(4):655-61
pubmed: 22505529
Genome Biol. 2016 Jun 03;17(1):121
pubmed: 27259475
J Infect Dis. 2010 Dec 15;202(12):1789-99
pubmed: 21067372
Nat Rev Immunol. 2002 Jan;2(1):28-36
pubmed: 11905835
Sex Transm Dis. 2014 Nov;41(11):660-4
pubmed: 25299412
Am J Pathol. 1998 Dec;153(6):1731-9
pubmed: 9846964
J Infect Dis. 2008 Jan 15;197(2):279-82
pubmed: 18179386
BMJ Open. 2016 Aug 26;6(8):e011371
pubmed: 27566633
Appl Environ Microbiol. 2008 Apr;74(8):2461-70
pubmed: 18296538
J Virol Methods. 2015 Apr;215-216:22-9
pubmed: 25698462
Obstet Gynecol. 2010 Dec;116(6):1373-80
pubmed: 21099605
Lancet Oncol. 2002 Jan;3(1):11-6
pubmed: 11905599
Gynecol Obstet Invest. 2016;81(1):41-6
pubmed: 26160018
Proc Biol Sci. 2015 Jan 7;282(1798):20141069
pubmed: 25429011
Curr Opin Microbiol. 2015 Jun;25:56-66
pubmed: 26005845
Vaccine. 2006 Mar 30;24 Suppl 1:S16-22
pubmed: 16219398
Microbiome. 2013 Dec 02;1(1):29
pubmed: 24451163
Int J Epidemiol. 2016 Jun;45(3):762-73
pubmed: 26944311

Auteurs

Carmen Lía Murall (CL)

MIVEGEC (UMR 5290 CNRS, IRD, UM), CNRS, Montpellier, France.

Massilva Rahmoun (M)

MIVEGEC (UMR 5290 CNRS, IRD, UM), CNRS, Montpellier, France.

Christian Selinger (C)

MIVEGEC (UMR 5290 CNRS, IRD, UM), CNRS, Montpellier, France.

Monique Baldellou (M)

Center for Free Information, Screening and Diagnosis (CGIDD), Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Claire Bernat (C)

MIVEGEC (UMR 5290 CNRS, IRD, UM), CNRS, Montpellier, France.

Marine Bonneau (M)

Department of Obstetrics and Gynaecology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Vanina Boué (V)

MIVEGEC (UMR 5290 CNRS, IRD, UM), CNRS, Montpellier, France.

Mathilde Buisson (M)

Department of Research and Innovation (DRI), Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Guillaume Christophe (G)

Center for Free Information, Screening and Diagnosis (CGIDD), Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Giuseppe D'Auria (G)

CIBER en Epidemiología y Salud Pública (CIBEResp), Madrid, Spain.
Sequencing and Bioinformatics Service, Fundaciónpara el Fomento de la Investigación Sanitaria y Biomédica de laComunidad Valenciana (FISABIO-Salud Pública), Valencia, Spain.

Florence De Taroni (F)

Center for Free Information, Screening and Diagnosis (CGIDD), Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Vincent Foulongne (V)

Pathogenesis and Control of Chronic Infections, INSERM, CHU, University of Montpellier, Montpellier, France.
Department of Virology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Rémy Froissart (R)

MIVEGEC (UMR 5290 CNRS, IRD, UM), CNRS, Montpellier, France.

Christelle Graf (C)

Department of Obstetrics and Gynaecology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Sophie Grasset (S)

MIVEGEC (UMR 5290 CNRS, IRD, UM), CNRS, Montpellier, France.
Center for Free Information, Screening and Diagnosis (CGIDD), Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Soraya Groc (S)

MIVEGEC (UMR 5290 CNRS, IRD, UM), CNRS, Montpellier, France.
Department of Virology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Christophe Hirtz (C)

LBPC/PPC- IRMB, CHU de Montpellier and Université de Montpellier, Montpellier, France.

Audrey Jaussent (A)

Department of Medical Information (DIM), Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Julie Lajoie (J)

Department of Medical microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.

Frédérique Lorcy (F)

Department of pathology and oncobiology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Eric Picot (E)

Center for Free Information, Screening and Diagnosis (CGIDD), Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Marie-Christine Picot (MC)

Department of Medical Information (DIM), Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Jacques Ravel (J)

Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Jacques Reynes (J)

Department of Infectious and Tropical Diseases, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Thérèse Rousset (T)

Department of pathology and oncobiology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Aziza Seddiki (A)

Department of Research and Innovation (DRI), Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Martine Teirlinck (M)

Center for Free Information, Screening and Diagnosis (CGIDD), Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Vincent Tribout (V)

Center for Free Information, Screening and Diagnosis (CGIDD), Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Édouard Tuaillon (É)

Pathogenesis and Control of Chronic Infections, INSERM, CHU, University of Montpellier, Montpellier, France.
Department of Virology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Tim Waterboer (T)

German Cancer Research Center (DKFZ), Infections and Cancer Epidemiology, Heidelberg, Germany.

Nathalie Jacobs (N)

GIGA-Research, Cellular and molecular immunology, University of Liège, Liège, Belgium.

Ignacio G Bravo (IG)

MIVEGEC (UMR 5290 CNRS, IRD, UM), CNRS, Montpellier, France.

Michel Segondy (M)

Pathogenesis and Control of Chronic Infections, INSERM, CHU, University of Montpellier, Montpellier, France.
Department of Virology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Nathalie Boulle (N)

Pathogenesis and Control of Chronic Infections, INSERM, CHU, University of Montpellier, Montpellier, France.
Department of pathology and oncobiology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Samuel Alizon (S)

MIVEGEC (UMR 5290 CNRS, IRD, UM), CNRS, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH